-
Je něco špatně v tomto záznamu ?
Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel CACNA1D Mutation
GC. Tan, G. Negro, A. Pinggera, NMS. Tizen Laim, I. Mohamed Rose, J. Ceral, A. Ryska, LK. Chin, NA. Kamaruddin, N. Mohd Mokhtar, AR. A Jamal, N. Sukor, M. Solar, J. Striessnig, MJ. Brown, EA. Azizan,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 1979 do Před 1 rokem
Open Access Digital Library
od 1979-01-01
Open Access Digital Library
od 1979-01-01
- MeSH
- adenom * genetika patologie MeSH
- aldosteron metabolismus MeSH
- dospělí MeSH
- dovnitř usměrňující draslíkové kanály spřažené s G proteiny genetika MeSH
- genetická predispozice k nemoci MeSH
- hyperaldosteronismus * genetika patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- nadledviny patologie MeSH
- nádory nadledvin * genetika patologie MeSH
- sodíko-draslíková ATPasa genetika MeSH
- vápníkové kanály - typ L genetika MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Mutations in KCNJ5, ATP1A1, ATP2B3, CACNA1D, and CTNNB1 are thought to cause the excessive autonomous aldosterone secretion of aldosterone-producing adenomas (APAs). The histopathology of KCNJ5 mutant APAs, the most common and largest, has been thoroughly investigated and shown to have a zona fasciculata-like composition. This study aims to characterize the histopathologic spectrum of the other genotypes and document the proliferation rate of the different sized APAs. Adrenals from 39 primary aldosteronism patients were immunohistochemically stained for CYP11B2 to confirm diagnosis of an APA. Twenty-eight adenomas had sufficient material for further analysis and were target sequenced at hot spots in the 5 causal genes. Ten adenomas had a KCNJ5 mutation (35.7%), 7 adenomas had an ATP1A1 mutation (25%), and 4 adenomas had a CACNA1D mutation (14.3%). One novel mutation in exon 28 of CACNA1D (V1153G) was identified. The mutation caused a hyperpolarizing shift of the voltage-dependent activation and inactivation and slowed the channel's inactivation kinetics. Immunohistochemical stainings of CYP17A1 as a zona fasciculata cell marker and Ki67 as a proliferation marker were used. KCNJ5 mutant adenomas showed a strong expression of CYP17A1, whereas ATP1A1/CACNA1D mutant adenomas had a predominantly negative expression (P value =1.20×10(-4)). ATP1A1/CACNA1D mutant adenomas had twice the nuclei with intense staining of Ki67 than KCNJ5 mutant adenomas (0.7% [0.5%-1.9%] versus 0.4% [0.3%-0.7%]; P value =0.04). Further, 3 adenomas with either an ATP1A1 mutation or a CACNA1D mutation had >30% nuclei with moderate Ki67 staining. In summary, similar to KCNJ5 mutant APAs, ATP1A1 and CACNA1D mutant adenomas have a seemingly specific histopathologic phenotype.
Barts Heart Centre William Harvey Research Institute Queen Mary University London United Kingdom
From the Department of Pathology The National University of Malaysia Medical Centre
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17030772
- 003
- CZ-PrNML
- 005
- 20171215163449.0
- 007
- ta
- 008
- 171025s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1161/HYPERTENSIONAHA.117.09057 $2 doi
- 035 __
- $a (PubMed)28584016
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Tan, Geok Chin $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.).
- 245 10
- $a Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel CACNA1D Mutation / $c GC. Tan, G. Negro, A. Pinggera, NMS. Tizen Laim, I. Mohamed Rose, J. Ceral, A. Ryska, LK. Chin, NA. Kamaruddin, N. Mohd Mokhtar, AR. A Jamal, N. Sukor, M. Solar, J. Striessnig, MJ. Brown, EA. Azizan,
- 520 9_
- $a Mutations in KCNJ5, ATP1A1, ATP2B3, CACNA1D, and CTNNB1 are thought to cause the excessive autonomous aldosterone secretion of aldosterone-producing adenomas (APAs). The histopathology of KCNJ5 mutant APAs, the most common and largest, has been thoroughly investigated and shown to have a zona fasciculata-like composition. This study aims to characterize the histopathologic spectrum of the other genotypes and document the proliferation rate of the different sized APAs. Adrenals from 39 primary aldosteronism patients were immunohistochemically stained for CYP11B2 to confirm diagnosis of an APA. Twenty-eight adenomas had sufficient material for further analysis and were target sequenced at hot spots in the 5 causal genes. Ten adenomas had a KCNJ5 mutation (35.7%), 7 adenomas had an ATP1A1 mutation (25%), and 4 adenomas had a CACNA1D mutation (14.3%). One novel mutation in exon 28 of CACNA1D (V1153G) was identified. The mutation caused a hyperpolarizing shift of the voltage-dependent activation and inactivation and slowed the channel's inactivation kinetics. Immunohistochemical stainings of CYP17A1 as a zona fasciculata cell marker and Ki67 as a proliferation marker were used. KCNJ5 mutant adenomas showed a strong expression of CYP17A1, whereas ATP1A1/CACNA1D mutant adenomas had a predominantly negative expression (P value =1.20×10(-4)). ATP1A1/CACNA1D mutant adenomas had twice the nuclei with intense staining of Ki67 than KCNJ5 mutant adenomas (0.7% [0.5%-1.9%] versus 0.4% [0.3%-0.7%]; P value =0.04). Further, 3 adenomas with either an ATP1A1 mutation or a CACNA1D mutation had >30% nuclei with moderate Ki67 staining. In summary, similar to KCNJ5 mutant APAs, ATP1A1 and CACNA1D mutant adenomas have a seemingly specific histopathologic phenotype.
- 650 12
- $a adenom $x genetika $x patologie $7 D000236
- 650 12
- $a nádory nadledvin $x genetika $x patologie $7 D000310
- 650 _2
- $a nadledviny $x patologie $7 D000311
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a aldosteron $x metabolismus $7 D000450
- 650 _2
- $a vápníkové kanály - typ L $x genetika $7 D020746
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a dovnitř usměrňující draslíkové kanály spřažené s G proteiny $x genetika $7 D051676
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a hyperaldosteronismus $x genetika $x patologie $7 D006929
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a sodíko-draslíková ATPasa $x genetika $7 D000254
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Negro, Giulia $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.).
- 700 1_
- $a Pinggera, Alexandra $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.).
- 700 1_
- $a Tizen Laim, Nur Maya Sabrina $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.).
- 700 1_
- $a Mohamed Rose, Isa $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.).
- 700 1_
- $a Ceral, Jiří $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.). $7 xx0060257
- 700 1_
- $a Ryška, Aleš, $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.). $d 1970- $7 nlk20020124969
- 700 1_
- $a Chin, Long Kha $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.).
- 700 1_
- $a Kamaruddin, Nor Azmi $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.).
- 700 1_
- $a Mohd Mokhtar, Norfilza $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.).
- 700 1_
- $a A Jamal, A Rahman $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.). $7 gn_A_00000001
- 700 1_
- $a Sukor, Norlela $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.).
- 700 1_
- $a Solar, Miroslav $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.).
- 700 1_
- $a Striessnig, Joerg $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.).
- 700 1_
- $a Brown, Morris Jonathan $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.).
- 700 1_
- $a Azizan, Elena Aisha $u From the Department of Pathology (G.C.T., N.M.S.T.L., I.M.R.), Department of Medicine (L.K.C., N.A.K., N.S., E.A.A.), and UKM Medical Molecular Biology Institute (UMBI) (N.M.M., A.R.A.J.), The National University of Malaysia Medical Centre; Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences, University of Innsbruck, Austria (G.N., A.P., J.S.); 1st Department of Internal Medicine-Cardioangiology (J.C., M.S.) and Department of Pathology (A.R.), Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Czech Republic; and Barts Heart Centre, William Harvey Research Institute, Queen Mary University London, United Kingdom (M.J.B.). elena.azizan@ukm.edu.my. $7 gn_A_00010731
- 773 0_
- $w MED00002089 $t Hypertension (Dallas, Tex. 1979) $x 1524-4563 $g Roč. 70, č. 1 (2017), s. 129-136
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28584016 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171215163529 $b ABA008
- 999 __
- $a ok $b bmc $g 1254365 $s 991799
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 70 $c 1 $d 129-136 $e 20170605 $i 1524-4563 $m Hypertension $n Hypertension $x MED00002089
- LZP __
- $a Pubmed-20171025